Crossject (PA:ALCJ) — Stock Price
Crossject (PA:ALCJ) is currently trading at €1.49 EUR, down 0.53% today. Over the past 52 weeks, shares have ranged between €1.40 and €2.69. This page tracks Crossject's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ALCJ company net worth.
Crossject (ALCJ) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Crossject's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Crossject Income Statement — Revenue, Profit & Earnings by Year
Crossject's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €0.00 | €4.12 Million | €145.00K | €954.00K | €912.00K |
| Cost of Revenue | €22.38 Million | €4.85 Million | €18.50 Million | €14.85 Million | €11.97 Million |
| Gross Profit | €-22.38 Million | €-21.89 Million | €-6.13 Million | €-13.89 Million | €-11.06 Million |
| Research & Development | — | — | €9.56 Million | €7.41 Million | €6.06 Million |
| SG&A | — | €8.08 Million | €7.98 Million | €7.60 Million | €6.38 Million |
| Total Operating Expenses | €-10.28 Million | €10.35 Million | €-3.95 Million | €12.08 Million | €975.00K |
| Operating Income | €-12.10 Million | €-15.24 Million | €-11.80 Million | €-13.23 Million | €-11.82 Million |
| EBITDA | €-7.21 Million | €-9.35 Million | €-7.30 Million | €-8.03 Million | €-7.33 Million |
| EBIT | €-12.10 Million | €-14.19 Million | €-11.80 Million | €-13.29 Million | €-11.82 Million |
| Interest Expense | €1.58 Million | €1.43 Million | €497.00K | €277.00K | €845.00K |
| Income Before Tax | €-13.18 Million | €-15.62 Million | €-11.51 Million | €-13.38 Million | €-12.62 Million |
| Income Tax Expense | €-2.82 Million | €-2.83 Million | €-2.87 Million | €-2.22 Million | €-1.82 Million |
| Net Income | €-10.37 Million | €-12.79 Million | €-8.64 Million | €-11.16 Million | €-10.81 Million |
Crossject Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Crossject's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €30.43 Million | €31.57 Million | €28.64 Million | €32.86 Million | €31.52 Million |
| Total Current Assets | €15.43 Million | €15.88 Million | €10.68 Million | €13.83 Million | €13.49 Million |
| Cash & Equivalents | — | — | — | — | €154.00K |
| Short-term Investments | — | — | — | — | €154.00K |
| Net Receivables | €5.89 Million | €4.29 Million | €4.78 Million | €3.52 Million | €1.67 Million |
| Inventory | €3.49 Million | €3.42 Million | €3.13 Million | €2.00 Million | €1.66 Million |
| Property, Plant & Equipment | €5.92 Million | €5.05 Million | €5.69 Million | €7.67 Million | €7.15 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €35.30 Million | €34.24 Million | €33.91 Million | €30.17 Million | €37.01 Million |
| Total Current Liabilities | €6.56 Million | €6.87 Million | €6.47 Million | €5.35 Million | €6.41 Million |
| Long-term Debt | €19.82 Million | €18.35 Million | €18.92 Million | €14.13 Million | €23.33 Million |
| Net Debt | €14.74 Million | €11.32 Million | €16.70 Million | €6.36 Million | €13.50 Million |
| Total Stockholder Equity | €-4.87 Million | €-2.67 Million | €-5.27 Million | €2.02 Million | €-6.15 Million |
| Retained Earnings | €-18.76 Million | €-15.39 Million | €-10.39 Million | €-19.94 Million | €-14.79 Million |
Crossject Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Crossject generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-6.35 Million | €-7.96 Million | €-6.20 Million | €-5.08 Million | €-6.08 Million |
| Capital Expenditures | €4.50 Million | €3.53 Million | €6.40 Million | €6.78 Million | €6.73 Million |
| Free Cash Flow | €-10.85 Million | €-11.48 Million | €-12.60 Million | €-11.86 Million | €-12.82 Million |
| Investing Cash Flow | €-4.46 Million | €-3.43 Million | €-2.64 Million | €-6.78 Million | €-6.73 Million |
| Financing Cash Flow | €8.85 Million | €16.13 Million | €3.36 Million | €9.64 Million | €14.52 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €4.89 Million | €5.22 Million | €4.50 Million | €5.26 Million | €4.49 Million |
| Change in Cash | €-1.96 Million | €4.75 Million | €-5.48 Million | €-2.06 Million | €1.71 Million |
Crossject Earnings History — EPS Actual vs. Analyst Estimates
Track Crossject's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 25, 2026 | — | — | — |
| Oct 31, 2025 | -0.10 | 0.00 | — |
| Sep 24, 2025 | 0.00 | 0.00 | — |
| Apr 29, 2025 | -0.13 | 0.00 | — |
| Mar 31, 2025 | — | — | — |
| Mar 20, 2023 | -0.14 | — | — |
| Sep 16, 2022 | -0.17 | — | — |
| Mar 24, 2022 | -0.19 | 0.00 | — |